Evidence map›Paper›PMID 38936878›Full record

ArticleThe Kobe journal of medical sciences2024

A Case of Olfactory Neuroblastoma Developing Bilateral Retropharyngeal Lymph Node Metastasis 14-years After Skull Base Surgery.

Marie Mizumoto, Tatsuya Furukawa, Mitsuko Yui, Keisuke Iritani, Shun Tatehara, Go Inokuchi, Masanori Teshima, Hirotaka Shinomiya, Hidehito Kimura, Naomi Kiyota and 2 more

Abstract readCase Reports
In one paragraph

Article in The Kobe journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marie MizumotoDepartment of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.
Tatsuya FurukawaDepartment of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.
Mitsuko YuiDepartment of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.
Keisuke IritaniDepartment of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.
Shun TateharaDepartment of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.
Go InokuchiDepartment of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.
Masanori TeshimaDepartment of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.
Hirotaka ShinomiyaDepartment of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.
Hidehito KimuraDepartment of Neurosurgery, Kobe University Hospital, Kobe, Japan.
Naomi KiyotaCancer Center, Kobe University Hospital, Kobe, Japan.
Ryohei SasakiDivision of Radiation Oncology, Kobe University Hospital, Kobe, Japan.
Ken-Ichi NibuDepartment of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Olfactory neuroblastoma (ONB) is an uncommon malignant tumor and is usually treated by a multidisciplinary approach includes surgery, radiotherapy, and chemotherapy. A 62 years-old male had a tumor in the nasal cavity and diagnosed as ONB with Kadish A stage. Anterior skull base surgery was performed as radical treatment. Since the surgical margin was negative, no postoperative radiotherapy was administered. 14 years after the surgery, bilateral otitis media with effusion (OME) was occurred, we found the recurrence tumor at bilateral retropharyngeal lymph node (RPLN) which surrounded the internal carotid arteries. Since these were unresectable, we planned chemoradiotherapy which was 70Gy of intensity modulated radiotherapy combined with two courses of carboplatin and etoposide. The tumor volume was reduced and bilateral OME were improved. He has been alive for 3 years after salvage treatment. Although ONB has a relatively good prognosis, it is known to often cause cervical lymph node metastasis. Grades III and IV of Hyams classification are considered high risk. This case, initial tumor was limited in the nasal cavity and its clinical classification was early stage, but Hyams classification was grade III. In reference to this case, considering that RPLN metastasis are difficult to radically resect at the salvage surgery, including this area in postoperative radiotherapy was considered an option.

Indexed as

Esthesioneuroblastoma, OlfactoryLymphatic MetastasisNasal CavityNose NeoplasmsChemoradiotherapyHumansMaleMiddle AgedNeoplasm Recurrence, LocalSkull BaseHyams gradeOlfactory neuroblastomaOtitis media with effusionPostoperative radiotherapyRetropharyngeal lymph node

Identifiers

PMID38936878
PMCPMC11216656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.